“Adhesion Barrier Market Report is set to have rapid growth due growing geriatric population, along with rising number of surgeries and sports-related injuries at global, regional and national level, influencing the industry trends in each of the sub-segments from 2019 to 2029”, says Visiongain Report
04 September 2019
Visiongain has launched a new pharma report Adhesion Barrier Market Forecast 2019-2029 : By Product (Synthetic, Natural), By Application (Cardiovascular, Neurological), By Formulation (Film/Mesh, Gel), Regional and Segment Forecasts.
The global Adhesion Barrier market is poised for rapid growth between 2019 and 2029. The growth of the geriatric population, together with the growing number of sports-related surgeries and injuries, should drive the market. Even the increasing cases of chronic diseases, such as cancer and neurological, gynecological, ophthalmic and dental disorders, contribute to market demand.
The treatment of these diseases requires surgical procedures and microsurgery in some cases, which is increasing the demand for adhesion barriers. For example, the prevalence of cancer is increasing, according to statistics published by the World Health Organization (WHO). About 8.2 million die of cancer each year, which represents 13.0% of deaths worldwide.
The leading companies included in the Report are Johnson & Johnson; Sanofi S.A.; Baxter International, Inc.; Becton, Dickinson and Company; Integra LifeSciences Holdings Corporation; Anika Therapeutics, Inc.; Atrium Medical Corporation (A Part of Getinge Group); FzioMed, Inc.; MAST Biosurgery, Inc.; and Innocoll Holdings PLC.
Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to email@example.com or call her on +44 (0) 207 336 6100.
Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.
Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.
Rising preference for personalised medicine in developed as well as developing economies coupled with increasing investment by biotechnological and pharmaceutical companies for drug discovery is expected to increase NGS market concentration over the forecast period.
04 June 2021
The rising frequency of bacterial and viral diseases coupled with increased focus on immunisation programmes are two main reasons that are expected to boost the global anti-infective vaccines market’s growth in the coming years.
04 June 2021
Rising incidences of infectious diseases is one of the prime factors driving the growth of the global anti-infective agents market globally.
27 May 2021
Healthcare has never been more personalized and affordable to anyone. Digital consulting applications use artificial intelligence to provide medical advice based on customized medical history record reviews and general medical information derived from big data inferences.